Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: Identification of gyrA and parC and specification of point mutations associated with resistance
Ss. Yan et al., Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: Identification of gyrA and parC and specification of point mutations associated with resistance, ANTIM AG CH, 44(11), 2000, pp. 3196-3198
A strain of Streptococcus pyogenes resistant to multiple fluoroquinolones w
as isolated from the blood of an immunocompromised patient. Resistance to f
luoroquinolones in S. pyogenes has not been previously studied. Compared to
10 sensitive strains of S. pyogenes, the fluoroquinolone-resistant clinica
l isolate of S, pyogenes presented point mutations in gyrA, predicting that
serine-81 was changed to phenylalanine and that methionine-99 was changed
to leucine, and in parC, predicting that serine-79 was changed to tyrosine.
The mechanism of fluoroquinolone resistance in this isolate of S. pyogenes
appears to be analogous to previously reported mechanisms for Streptococcu
s pneumoniae.